Search results
What Medicare beneficiaries need to know about generic medications
Fortune via AOL· 1 day agoAdvice for Part D plan shopping When Medicare Open ...Plan Finder tool on Medicare’s site to ...
Cigna Medicare Advantage Plans 2024 Review - NerdWallet
Nerdwallet· 5 days agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Cigna plans are...
Comment: Turning 65? Here’s what to know about Medicare | HeraldNet.com
Everett Herald· 18 hours agoFor many Washington residents, the transition from an employer-sponsored health insurance plan to Medicare may feel overwhelming. New Medicare& ...
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
Zacks via Yahoo Finance· 1 day agoDVA’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise...
Navigating the Complexities of FEHB & Medicare in Retirement
TheStreet.com· 6 days agoUnlock the secrets of retirement healthcare with Jae Oh's expert tips on navigating FEHB and Medicare complexities.
Q1 2024 scPharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 11 hours agoTo that end, earlier this month, we submitted a supplemental new drug application with the FDA for the CKD indication. At this point, I'll turn the call over to our Senior ...
Sage Transparency™ Relaunches With New Features and New RAND Hospital Price Data
NBC 10 - FOX 14 Monroe· 3 days agoSage Transparency, which was first made available in 2022, is a browser-based dashboard that helps inform employers, policymakers, and more on the...000 hospitals and 2,000 ...
Earnings call: Arcutis Biotherapeutics reports strong Q1 2024 growth By Investing.com
Investing.com· 11 hours agoArcutis Biotherapeutics (NASDAQ:ARQT) has announced robust financial results for the first quarter...
Kids and Anti-Obesity Meds: Real-World Challenges
Medscape· 6 days agoThe ability to provide adolescents with highly effective anti-obesity medications that now carry approvals from the US Food and Drug Administration (FDA)...
Earnings call: Harrow Inc. reports robust revenue growth in Q1 2024 By Investing.com
Investing.com· 1 day agoHarrow, Inc. (ticker not provided), a prominent player in the ophthalmic pharmaceuticals industry,...